The CIDG editorial base bid a fond farewell to Dr Rebecca Kuehn (pictured centre) in September 2024.

Having joined the CIDG editorial based as a Clinical Research Associate in November 2021, Rebecca has led a number of Cochrane reviews with READ-It Partners and others, covering a variety of topics related to post COVID-19 condition, mpox, typhoid, echinococcosis. She has also contributed as co-author on COVID-19, travellers’ diarrhoea, and mass drug administration for soil-transmitted helminths topics.

Rebecca was also involved in supporting World Health Organization guideline development. She has scoped, appraised, synthesized, and presented the core evidence base to World Health Organization Guideline Development Groups on the treatment of cystic echinococcosis, mpox infection prevention and control, and therapeutics for mpox. 

At LSTM, she taught critical appraisal, systematic review skills and GRADE methodology on the Diploma in Tropical Medicine & Hygiene (DTM&H). She was also a member of the LSTM MSc Ethics panel and a member of the Board of Examiners for the DTM&H.

Rebecca has been awarded a fellowship to undertake a PhD at McMaster University in Canada. Under the supervision of Professor Gordon Guyatt in the Department of Health Research Methods, Evidence, and Impact, she will be undertaking a thesis exploring the risk of bias in non-randomised studies of heath interventions. 

On behalf of the CIDG editorial team, we wish her all the very best as she embarks on the next stage of her exciting career!